Quest Diagnostics Incorporated (DGX)vsDanaher Corporation (DHR)
DGX
Quest Diagnostics Incorporated
$250.81
-0.40%
HEALTHCARE · Cap: $27.11B
DHR
Danaher Corporation
$230.08
+0.94%
HEALTHCARE · Cap: $163.25B
Smart Verdict
WallStSmart Research — data-driven comparison
Danaher Corporation generates 116% more annual revenue ($25.61B vs $11.84B). DHR leads profitability with a 16.9% profit margin vs 9.5%. DHR appears more attractively valued with a PEG of 1.32. DHR earns a higher WallStSmart Score of 65/100 (B-).
DGX
Buy64
out of 100
Grade: C+
DHR
Strong Buy65
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-87.2%
Fair Value
$111.82
Current Price
$250.81
$138.99 premium
Intrinsic value data unavailable for DHR.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 28.7% YoY
Large-cap with strong market position
Strong operational efficiency at 21.1%
Earnings expanding 37.8% YoY
Generating 1.6B in free cash flow
Areas to Watch
Expensive relative to growth rate
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : DGX
The strongest argument for DGX centers on EPS Growth.
Bull Case : DHR
The strongest argument for DHR centers on Market Cap, Operating Margin, EPS Growth. Profitability is solid with margins at 16.9% and operating margin at 21.1%. PEG of 1.32 suggests the stock is reasonably priced for its growth.
Bear Case : DGX
The primary concerns for DGX are PEG Ratio.
Bear Case : DHR
The primary concerns for DHR are P/E Ratio.
Key Dynamics to Monitor
DGX profiles as a value stock while DHR is a mature play — different risk/reward profiles.
DHR carries more volatility with a beta of 0.80 — expect wider price swings.
DGX is growing revenue faster at 10.0% — sustainability is the question.
DHR generates stronger free cash flow (1.6B), providing more financial flexibility.
Bottom Line
DHR scores higher overall (65/100 vs 64/100), backed by strong 16.9% margins. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Quest Diagnostics Incorporated
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Danaher Corporation
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company's 3 platforms are Life Sciences, Diagnostics, and Environmental & Applied Solutions.
Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?